Browse the evidence

HOMA-IR loses diagnostic accuracy for metabolic syndrome in non-diabetic women over 70 years of age, rendering it an unreliable screening tool for this specific subgroup.

If you are a non-diabetic woman over 70, a HOMA-IR test may not accurately reflect your metabolic risk. The study suggests this test becomes unreliable in this age group. Focus on direct measures of metabolic health: monitor blood pressure, lipid profiles, waist circumference, and blood glucose directly, as these are more robust indicators for your demographic.

Diet and physical activity based interventions during pregnancy do not significantly reduce the risk of composite maternal or offspring outcomes, nor individual outcomes like gestational diabetes, hypertensive disorders, or preterm delivery in IPD meta-analysis.

While lifestyle interventions may not significantly reduce the risk of all maternal and offspring complications combined, they do reduce weight gain and caesarean section risk. Focus on these proven benefits.

Carriers of the TM6SF2 E167K genetic variant exhibit increased susceptibility to progressive nonalcoholic steatohepatitis (NASH) and advanced fibrosis due to impaired hepatic secretion of very-low-density lipoproteins (VLDL), resulting in toxic triglyceride accumulation in hepatocytes.

If you have the TM6SF2 E167K genetic variant, your liver is less efficient at exporting fat. This means fat builds up in your liver cells, causing inflammation and scarring (NASH/fibrosis) even if your blood lipid levels are low. Standard 'fatty liver is benign' advice may be dangerous for you; you require closer monitoring of liver health via biopsy or advanced imaging if risk factors are present.

In nonalcoholic fatty liver disease (NAFLD), hepatic de novo fatty acid synthesis and uptake are up-regulated (increased ACC1, FAS, SREBP-1c, ADRP) despite existing fatty acid accumulation, driven by a failure of negative feedback regulation.

In NAFLD, the body's normal ability to shut down fat production when fat stores are high is broken. Instead of turning off synthesis, the liver continues to produce and take up fatty acids actively. This suggests that simply reducing dietary fat may not be sufficient if the underlying hormonal regulation (insulin/SREBP-1c) is not addressed.

Silencing estrogen receptor alpha (ERα) specifically in the ventromedial nucleus of the hypothalamus (VMN) causes metabolic syndrome in female mice and rats, characterized by obesity, hyperphagia, glucose intolerance, and reduced energy expenditure.

This research highlights the critical role of estrogen receptor alpha (ERα) in the ventromedial nucleus of the hypothalamus (VMN) in regulating energy balance. Silencing this receptor leads to metabolic syndrome, including obesity, hyperphagia, and reduced energy expenditure. While this is a preclinical study using viral vectors, it underscores the importance of hormonal signaling in the brain for maintaining healthy body weight and metabolism.

Estrogen (E2) reduces adiposity and adipocyte size independently of energy intake by down-regulating lipogenic genes (SREBP-1c, FAS, ACC-1) and up-regulating lipid oxidation pathways (PPAR-alpha, AMPK) in skeletal muscle and adipose tissue.

If you are post-menopausal or have low estrogen, you may experience increased abdominal fat storage due to metabolic changes, not just eating more. Estrogen replacement therapy can help maintain leanness by shifting your body to burn fat rather than store it, acting directly on your muscles and fat cells.

Fibrosis and inflammation significantly confound steatosis biomarkers, causing them to yield higher values in patients with advanced fibrosis or NASH even when the amount of liver fat is similar.

If your steatosis biomarker score is high, do not assume you have severe fatty liver. It may be elevated due to liver inflammation or scarring (fibrosis). These markers are not specific to fat alone.

Increasing the training sample size of DNA methylation-based epigenetic clocks improves prediction accuracy of chronological age, which attenuates the association between age acceleration residuals (AAR) and mortality, suggesting previous associations were confounded by cellular composition.

Current 'epigenetic clocks' (like Horvath or Hannum) that claim to measure 'biological age' and predict mortality may be flawed because they are confounded by blood cell counts. Using larger, more precise datasets to build these clocks removes the mortality prediction, suggesting these clocks measure chronological time accurately but do not necessarily predict healthspan or lifespan. Do not rely on standard AAR metrics for mortality risk assessment without adjusting for cellular composition.

Postdevelopmental inactivation of evolutionarily conserved essential genes (via RNAi) extends adult lifespan in C. elegans, with some inactivations extending lifespan as robustly as the strongest known regulators like daf-2.

This study in worms shows that turning down certain essential genes after adulthood can significantly extend lifespan, often through insulin-like signaling pathways. While direct application to humans is not possible, it highlights that aging is a regulated biological process influenced by conserved genetic pathways, suggesting that interventions targeting these pathways (like insulin signaling) might be viable strategies for longevity.

Circulating levels of soluble CD36 (sCD36) are abnormally elevated in NAFLD patients and positively correlate with the histological grade of hepatic steatosis, suggesting its utility as a biomarker.

Soluble CD36 levels in the blood may serve as a biomarker to assess the severity of fatty liver disease. This is a diagnostic tool rather than a treatment target for patients at this stage.

MCP-1/CCR2 and RANTES/CCR5 chemokine signaling pathways are critical for macrophage recruitment and the progression of hepatic steatosis to NASH.

Chemokines like MCP-1 and RANTES recruit inflammatory immune cells to the liver, worsening NAFLD. Blocking these pathways (currently experimental) or reducing their expression through diet/lifestyle may help mitigate liver inflammation.

Colonization of germfree mice with a human-derived microbiome (HBF) significantly alters host lipid metabolism by increasing ileal tauro-conjugated bile acids, which leads to reduced plasma lipoproteins but increased hepatic triglyceride storage and glutathione depletion.

Your gut bacteria directly influence how your body handles fats. Introducing specific microbial communities can shift your bile acid profile, which in turn affects how much fat is stored in your liver versus circulating in your blood. While this study used mice, it highlights that microbiome composition is a key driver of lipid metabolism, not just diet alone.

In Type 1 Diabetes (T1D), functional impairment of beta cells occurs early in the prediabetic phase, whereas a substantial decrease in beta cell mass occurs late, close to clinical manifestation.

For T1D, preserving existing beta cell function early is as critical as replacing mass later. Treatments aiming to restore function (like those inducing the 'honeymoon phase') may be more effective if applied early, before massive cell death occurs.

Breast milk oligosaccharides (HMOs) selectively promote the growth of specific beneficial bacteria (Bifidobacterium longum subsp. infantis) and shape the infant gut microbiota towards a state that supports immune development and digestion.

For parents, breast milk is the optimal source for establishing a healthy infant gut microbiota due to HMOs. If breastfeeding is not possible, look for formulas containing prebiotics (GOS/FOS) to help mimic some of these beneficial microbial shifts.

Peripheral leptin action (on pancreas, muscle, liver) is not required for normal energy balance or body weight regulation in mice, as peripheral LEPRb deletion does not alter these metrics.

While leptin affects organs like the liver and muscle, its main job for weight control is signaling to the brain. Peripheral effects are secondary to the central nervous system's regulation.

Endogenous levels of DHEAS (dehydroepiandrosterone sulfate) are not clearly associated with the presence of severe aortic atherosclerosis in either elderly men or women.

For men and women over 55, your natural DHEAS levels are not a reliable indicator of whether you have severe aortic atherosclerosis. Unlike testosterone, DHEAS does not show a clear protective association with the presence of the disease. Focus on proven risk factors like blood pressure, cholesterol, and smoking status.

Unsupervised ingestion of micronutrient supplements, particularly multivitamins and iron, is a major cause of emergency department visits in young children (≤4 years).

Keep all supplements, especially multivitamins and iron, in child-resistant containers and out of reach of young children. Treat them with the same caution as prescription medications.

Higher frequency of fish and shellfish consumption is directly associated with significantly higher blood organic (methyl) mercury concentrations in adult women.

If you eat fish frequently (more than twice a week), your blood mercury levels will be significantly higher than non-consumers. To minimize risk, vary your seafood choices, limiting high-mercury species like shark, swordfish, and king mackerel, and stick to lower-mercury options like salmon and shrimp.

A significant portion of newborns in the US are exposed in utero to methyl mercury levels considered to carry an increased risk of adverse neurodevelopmental effects, primarily driven by high fish consumption in specific demographic groups.

If you are pregnant or planning to be, your fish choices directly impact your baby's brain development. Over 300,000 US babies are exposed to risky mercury levels annually. To protect your baby, avoid high-mercury fish (shark, swordfish, king mackerel, tilefish) and choose low-mercury options (salmon, shrimp, canned light tuna, pollock).

Differentiation of white adipocytes involves a 20- to 30-fold increase in mitochondrial protein concentration and density, indicating that mitochondrial biogenesis is a fundamental aspect of white adipose cell differentiation.

This research highlights that white fat cells are metabolically active and build significant mitochondrial capacity during differentiation. While this is a cellular mechanism rather than a direct human intervention, it suggests that promoting healthy adipose tissue differentiation may support overall metabolic health and insulin sensitivity.

Treatment with the PPAR-gamma agonist rosiglitazone increases mitochondrial density and alters mitochondrial morphology (shorter, denser profiles with lamellar cristae) in differentiated white adipocytes.

Rosiglitazone, a PPAR-gamma agonist, increases mitochondrial density and changes their structure in fat cells. This cellular remodeling may contribute to the drug's ability to improve insulin sensitivity, although its clinical use is limited by safety profiles.

Nordihydroguaiaretic acid (NDGA) extends median lifespan in male mice across multiple doses, but has no effect on female lifespan even when blood levels are matched to males.

NDGA extends the lifespan of male mice in a dose-dependent manner, but has no effect on female lifespan, even when blood levels are matched to those of males. This indicates a fundamental sex-specific difference in how NDGA affects longevity.

Surgical removal of adipose tissue and specific genetic modifications (e.g., deletion of diacylglycerol acyltransferase 1) extend lifespan in rodents.

In rodents, removing fat or modifying specific fat-synthesis genes extends life. This highlights the critical role of adipose tissue in aging. For humans, this suggests that managing body fat levels is crucial for healthspan, though surgical removal is not a viable longevity strategy.

Exposure to Endocrine-Disrupting Chemicals (EDCs) such as Bisphenol A (BPA) and Diethylstilbestrol (DES) during fetal development can cause transgenerational epigenetic changes leading to increased risks of cancer, obesity, and reproductive disorders in offspring and subsequent generations.

Minimize exposure to endocrine disruptors like BPA (found in some plastics) and DES-like compounds. Use glass or stainless steel containers for food storage, avoid heating food in plastic, and choose fresh foods over canned when possible to reduce intake of these chemicals, especially during pregnancy.